M&T Bank Corp Purchases 138 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
M&T Bank Corp grew its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,301 shares of the biopharmaceutical company’s stock after purchasing an additional 138 shares during the quarter. M&T […]
M&T Bank Corp grew its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,301 shares of the biopharmaceutical company’s stock after purchasing an additional 138 shares during the quarter. M&T […]
